EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Development Path of Gynecological Cytology after Papanicolaou: From Bethesda to Artificial Intelligence and Personalized Medicine

Ivana Kholová, Christine N Booth, Henrik Edvardsson, Ritu Nayar, Giovanni Negri, Liron Pantanowitz

Acta Cytologica · 01.07.2026 · 1-13

DOI: 10.1159/000552509 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Cytologica, online erschienen am 01.07.2026. Verfasst von Ivana Kholová und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland, ivana.kholova@uef.fi. Die Arbeit nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Cervical cancer is the fourth most common cancer whose incidence was significantly reduced with the help of Pap smear and organized cervical cancer screening. Implementation of HPV vaccination and addition of HPV primary screening, automation, and most recently digitalization and application of artificial intelligence have taken cervical cancer prevention into a new era. Summary: This review paper covers gynecological cytology from terminology and shows The Bethesda System as a model for further terminology systems. Liquid-based cytology enabled the application of ancillary techniques elegantly from one vial as well as digitalization and the implementation of artificial intelligence. HPV primary screening further shaped the field and led to the decline of cytology volumes. Nevertheless, genotyping and dual staining allow the implementation of personalized medicine in screening scenarios. Key Messages: The field of gynecological cytology has slowly but surely evolved from the conventional Pap smear to liquid-based cytology, automation, and now digitalization, artificial intelligence, and inclusion of HPV testing with genotyping enabling personalized prevention in cervical cancer screening and diagnostics.

Schlagwörter

Stichwörter der Autor:innen

Bethesda systemCervical cancerDigital cytologyGynecological cytologyHPV primary screeningLiquid-based cytology

Autor:innen und Institutionen

  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland, ivana.kholova@uef.fi.
  • Department of Pathology, Fimlab Laboratories, Tampere, Finland, ivana.kholova@uef.fi.
  • Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland, ivana.kholova@uef.fi.
  • Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
  • Northwestern University, Feinberg School of Medicine-Northwestern Memorial Hospital, Chicago, Illinois, USA.

Zitieren

APA

Kholová, I., Booth, C. N., Edvardsson, H., Nayar, R., Negri, G., & Pantanowitz, L. (2026). The Development Path of Gynecological Cytology after Papanicolaou: From Bethesda to Artificial Intelligence and Personalized Medicine. Acta Cytologica, 1-13. https://doi.org/10.1159/000552509

Vancouver

Kholová I, Booth CN, Edvardsson H, Nayar R, Negri G, Pantanowitz L. The Development Path of Gynecological Cytology after Papanicolaou: From Bethesda to Artificial Intelligence and Personalized Medicine. Acta Cytologica. 2026:1-13. doi:10.1159/000552509

BibTeX
@article{Kholov2026,
  author = {Kholová, Ivana and Booth, Christine N and Edvardsson, Henrik and Nayar, Ritu and Negri, Giovanni and Pantanowitz, Liron},
  title = {The Development Path of Gynecological Cytology after Papanicolaou: From Bethesda to Artificial Intelligence and Personalized Medicine},
  journal = {Acta Cytologica},
  year = {2026},
  pages = {1--13},
  doi = {10.1159/000552509}
}
Kostenlos starten →